EODData

MEMBERSHIP REGISTER LOG IN

NSE, JUBLPHARMA: Jubilant Pharmova Limited

30 Dec 2025
LAST:

1,041

CHANGE:
 12.20		OPEN:
1,053		HIGH:
1,070		ASK:
0		VOLUME:
103.3K
CHG(%):
1.16		PREV:
1,053		LOW:
1,029		BID:
0		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
30 Dec 251,0531,0701,0291,041103.3K
29 Dec 251,0731,0781,0481,05367.0K
26 Dec 251,0571,0771,0571,07567.4K
24 Dec 251,0881,0881,0601,06767.2K
23 Dec 251,0821,0861,0711,08248.6K
22 Dec 251,0831,0931,0711,08181.2K
19 Dec 251,0551,1001,0551,087385.4K
18 Dec 251,0481,0601,0361,05558.7K
17 Dec 251,0621,0671,0431,05143.5K
16 Dec 251,0811,0811,0601,060102.4K

PROFILE

Name:Jubilant Pharmova Limited
About:Jubilant Pharmova Limited operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research Development and Manufacturing Organisation; and Proprietary Novel Drugs. The Radiopharma segment offers radiopharmaceuticals products, which are used in the diagnosis and treatment of various diseases, including pulmonary embolism, cancer, coronary artery disease, and others. Its Allergy Immunotherapy segment provides specialised diagnostic devices for skin testing, as well as venom and allergy immunotherapy products. The Contract Development and Manufacturing Organisation - Sterile Injectables segment offers contract manufacturing services for sterile fill and finish injectables, liquids, ointments, creams, and ampoules. Its Generics segment engages in the development, manufacturing, distribution, sale, and marketing of generic formulations for therapeutic areas comprising cardiovascular system, central nervous system, gastrointestinal, antibiotics, and multispecialty. The Contract Research Development and Manufacturing Organisation segment offers drug discovery services and active pharmaceutical ingredients. The Proprietary Novel Drugs segment provides patient-focused biopharmaceutical services to address unmet medical needs in oncology and autoimmune diseases. The company serves pharmaceutical, biotech, group purchasing organisations, allergists, and hospitals sectors. It sells its products through a network of dealers and distributors. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. The company was incorporated in 1978 and is based in Noida, India.
Sector:Healthcare
Address:1A, Sector 16A, Noida, India, 201301
Website:https://www.jubilantpharmova.com
ISIN:INE700A01033

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:35.71 
Forward P/E:22.29 
PEG Ratio:-0.45 
Price to Sales:2.23 
Price to Book:2.58 
Profit Margin:0.06 
Operating Margin:0.12 
Return on Assets:0.04 
Return on Equity:0.08 
Revenue:76.176B 
EBITDA:12.483B 
Shares:158.4M 
Market Cap:164.86B 

TECHNICAL INDICATORS

MA5:1,063.382.2%
MA10:1,065.012.3%
MA20:1,068.672.7%
MA50:1,098.605.6%
MA100:1,092.605.0%
MA200:1,068.902.7%
RSI14:48.70
WPR14:-100.00 
MTM14:-24.90
ROC14:-0.02 
ATR:27.39 
Week High:1,088.004.5%
Week Low:1,028.801.2%
Month High:1,118.507.5%
Month Low:1,011.002.7%
Year High:1,248.0019.9%
Year Low:802.0029.8%
Volatility:19.80 

RECENT SPLITS

Date Ratio
25 Nov 201021-20
17 Mar 20065-1

RECENT DIVIDENDS

Date Amount
25 Jul 2025$5.00
02 Aug 2024$5.00
10 Aug 2023$5.00
11 Aug 2022$5.00
05 Aug 2021$5.00
09 Mar 2020$5.00
12 Sep 2019$4.50
12 Sep 2018$3.00
16 Aug 2017$3.00
18 Aug 2016$3.00